• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: DEPRESSION

Emerging data on bullying as a risk factor for depression, anxiety

December 16, 2015  

Suicide: the Toronto experience

May 13, 2015  

From Framingham to Facebook: the contagion of controversy

April 1, 2015  

Augmentation in treatment-resistant depression: meta-analyses

October 8, 2014  

Combining drug and psychotherapy more effective for depression, anxiety

September 24, 2014  

APA 2014: New Research – Part 1

June 25, 2014  

Depression and discrimination: the ASPEN/INDIGO study

February 19, 2014  

Recurrent depression in the community: NEMESIS results

October 23, 2013  

Web-based CBT effective for depression, QOL

May 8, 2013  

Combination therapy superior to monotherapy for psychotic depression

November 7, 2012  
1
2
3
4

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ultomiris (ravulizumab) now publicly reimbursed in gMG posted on April 7, 2026
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions